136 related articles for article (PubMed ID: 3045537)
1. Induction of chromosomal aberrations in rat bone marrow cells and mutations in Salmonella typhimurium by benz[a]anthracene derivatives.
Ito Y; Ueda N; Maeda S; Murao S; Sugiyama T; Lee H; Harvey RG
Mutat Res; 1988 Sep; 206(1):55-63. PubMed ID: 3045537
[TBL] [Abstract][Full Text] [Related]
2. Mutagenicity of cyclopenta-fused isomers of benz(a)anthracene in bacterial and rodent cells and identification of the major rat liver microsomal metabolites.
Nesnow S; Leavitt S; Easterling R; Watts R; Toney SH; Claxton L; Sangaiah R; Toney GE; Wiley J; Fraher P
Cancer Res; 1984 Nov; 44(11):4993-5003. PubMed ID: 6386146
[TBL] [Abstract][Full Text] [Related]
3. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.
Utesch D; Glatt H; Oesch F
Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447
[TBL] [Abstract][Full Text] [Related]
4. Comparative regioselective and stereoselective metabolism of 7-chlorobenz[a]anthracene and 7-bromobenz[a]anthracene by mouse and rat liver microsomes.
Fu PP; Von Tungeln LS; Unruh LE; Ni YC; Chou MW
Carcinogenesis; 1991 Mar; 12(3):371-8. PubMed ID: 2009583
[TBL] [Abstract][Full Text] [Related]
5. Mutagenicity of dibenz[a,c]anthracene and its derivatives in Salmonella typhimurium TA100.
Kumar S; Kole PL; Sikka HC
Mutat Res; 1990 Dec; 242(4):337-43. PubMed ID: 2255327
[TBL] [Abstract][Full Text] [Related]
6. The mutagenicity of dibenz[a,j]acridine, some metabolites and other derivatives in bacteria and mammalian cells.
Bonin AM; Rosario CA; Duke CC; Baker RS; Ryan AJ; Holder GM
Carcinogenesis; 1989 Jun; 10(6):1079-84. PubMed ID: 2655962
[TBL] [Abstract][Full Text] [Related]
7. Stereoselectivity of rat liver microsomal enzymes in the metabolism of 7-fluorobenz(a)anthracene and mutagenicity of metabolites.
Chiu PL; Fu PP; Yang SK
Cancer Res; 1984 Feb; 44(2):562-70. PubMed ID: 6692361
[TBL] [Abstract][Full Text] [Related]
8. Induction of hepatic glutathione transferase and suppression of 7,12-dimethylbenz[a]anthracene-induced chromosome aberrations in rat bone marrow cells by Sudan III and related azo dyes.
Ito Y; Maeda S; Souno K; Ueda N; Sugiyama T
J Natl Cancer Inst; 1984 Jul; 73(1):177-83. PubMed ID: 6204095
[TBL] [Abstract][Full Text] [Related]
9. Mutagenicity of benzo[a]pyrene 7,8-dihydrodiol and 7,12-dimethylbenz[a]anthracene 3,4-dihydrodiol in S. typhimurium mediated by microsomes from rat liver and mouse skin.
Camus AM; Pyerin WG; Grover PL; Sims P; Malaveille C; Bartsch H
Chem Biol Interact; 1980 Nov; 32(3):257-65. PubMed ID: 6775825
[TBL] [Abstract][Full Text] [Related]
10. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
Glatt H; Seidel A; Bochnitschek W; Marquardt H; Marquardt H; Hodgson RM; Grover PL; Oesch F
Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
[TBL] [Abstract][Full Text] [Related]
11. High mutagenic potency of several polycyclic aromatic hydrocarbons induced by liver postmitochondrial fractions from control and xenobiotic-treated immature carp.
Protić-Sabljić M; Kurelec B
Mutat Res; 1983 Aug; 118(3):177-89. PubMed ID: 6348528
[TBL] [Abstract][Full Text] [Related]
12. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
Irwin RD
Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
[TBL] [Abstract][Full Text] [Related]
13. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of 6-methylbenz[a]anthracene by rat liver microsomes and mutagenicity of metabolites.
Mushtaq M; Fu PP; Miller DW; Yang SK
Cancer Res; 1985 Sep; 45(9):4006-14. PubMed ID: 3896475
[TBL] [Abstract][Full Text] [Related]
15. Mutagenicity of the enantiomers of the diastereomeric bay-region benz(a)anthracene 3,4-diol-1,2-epoxides in bacterial and mammalian cells.
Wood AW; Chang RL; Levin W; Yagi H; Thakker DR; van Bladeren PJ; Jerina DM; Conney AH
Cancer Res; 1983 Dec; 43(12 Pt 1):5821-5. PubMed ID: 6357432
[TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide: lack of mutagenic activity across phyla and genetic endpoints.
Ashby J; Tinwell H; Callander RD; Kimber I; Clay P; Galloway SM; Hill RB; Greenwood SK; Gaulden ME; Ferguson MJ; Vogel E; Nivard M; Parry JM; Williamson J
Mutat Res; 1997 Dec; 396(1-2):45-64. PubMed ID: 9434859
[TBL] [Abstract][Full Text] [Related]
18. Mutagenicity of nitro derivatives produced by exposure of dibenzofuran to nitrogen oxides.
Watanabe T; Hirayama T
Mutat Res; 1992 Sep; 283(1):35-43. PubMed ID: 1380661
[TBL] [Abstract][Full Text] [Related]
19. Oxidation of the trans-3,4-dihydrodiol metabolites of the potent carcinogen 7,12-dimethylbenz(a)anthracene and other benz(a)anthracene derivatives by 3 alpha-hydroxysteroid-dihydrodiol dehydrogenase: effects of methyl substitution on velocity and stereochemical course of trans-dihydrodiol oxidation.
Smithgall TE; Harvey RG; Penning TM
Cancer Res; 1988 Mar; 48(5):1227-32. PubMed ID: 3124956
[TBL] [Abstract][Full Text] [Related]
20. Comparison of mutagenesis and malignant transformation by dihydrodiols from benz[a]anthracene and 7,12-dimethylbenz[a]anthracene.
Marquardt H; Baker S; Tierney B; Grover PL; Sims P
Br J Cancer; 1979 May; 39(5):540-7. PubMed ID: 114201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
